VKH
DGX icon

Virtu KCG Holdings’s Quest Diagnostics DGX Stock Holding History

Virtu KCG Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,700
Closed -$414K – 3859
2013
Q3 		$414K Buy
+6,700
New +$401K 0.01% 2228

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Virtu KCG Holdings's DGX Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Quest Diagnostics (DGX) stake by 48% in Q2 2017, selling an estimated $970K and leaving 9,784 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #528.

Virtu KCG Holdings first reported a position in DGX in Q3 2013 and has held it in 15 quarters since. The position peaked at $1.86M in Q1 2017. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Virtu KCG Holdings held 9,784 shares of Quest Diagnostics worth $1.09M as of Q2 2017.
  • Virtu KCG Holdings sold 9,171 Quest Diagnostics shares in Q2 2017, an estimated $970K.
  • Quest Diagnostics made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #528 holding.
  • Virtu KCG Holdings first reported a position in Quest Diagnostics in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Quest Diagnostics position peaked at $1.86M in Q1 2017.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.